Abstract:Objective To evaluate the effect of intracoronary autologous bone marrow mononuclear cells (ABMMNCs) transplantation on cardiac function of dilated cardiomyopathy (DCM). Methods and Results A total of 16 patients were divided into 2 groups according to patients' will. The transplantation group (n=10) were transplanted with ABMMNCs through coronary artery additional to drugs therapy while the control group (n=6) received drugs therapy only. After 6 months of follow-up, a significant increase of left ventricular ejection fraction (LVEF) determined by ultrasonic cardiography was observed in the transplantation group. The left ventricular diastolic diameter (LVDd) and the left ventricular systolic diameter (LVSd) decreased significantly and also the left arterial diameter (LAD) decreased in the transplatation group. In the control group improvement in LVEF, LVDd and LVSd were observed, but there's no significant difference (P0.05). No procedure related complications and malignant arrhythmia were found during 6-12 months follow-up. Conclusion Intracoronary transplantation of ABMMNCs is safe and may improve the heart function.

Amelioration of Heart Function by Intracoronary Autologous Bone Marrow Mononuclear Cells Transplantation in Idiopathic Dilated Cardiomyopathy: a Clinical Study